MCADDI 2026: Registrations are now closed. Thank you for the overwhelming response!
MCADDI 2026
University of Hyderabad, India
Medicinal Chemistry,
Drug Discovery &
Development India
The complete journey — from target identification to clinical development
🔒 Registrations Closed
View Program →
Registrations for MCADDI 2026 are now closed. Registered participants will receive joining details by email.
6Days of learning
30+Expert speakers
150+Participants expected
7+Countries
Organised by
FABA
Science Gurus
Biocon Academy
Univ. of Hyderabad
Aragen
About the program
Where Chemistry
Meets Clinical Reality
MCADDI is a globally recognized program presenting the full spectrum of drug discovery and development — from medicinal chemistry principles to advanced biologics, clinical translation, and manufacturing. Built for scientists actively working in or moving into the field.
MCADDI 2026 marks a landmark edition — brought to Hyderabad for the first time in collaboration with FABA, Science Gurus, and the University of Hyderabad, building on four successful prior editions.
Group photo from MCADDI 2024, Biocon Academy, Bangalore
Global industry & academic faculty
Speakers from BMS, Genentech, AbbVie, Merck, Amgen, Sun Pharma, Schrodinger and leading research institutions worldwide.
Interactive case-based sessions
Highly interactive lectures with real drug discovery case histories — from concept to approved medicine.
CEO conclave & keynote banquet
Exclusive fireside chat with pharma & biotech CEOs, followed by a networking banquet — a signature MCADDI event.
Novel modalities & AI in pharma
Dedicated sessions on ADCs, PROTACs, molecular glues, biologics, and AI-driven drug design.
Track record
A Decade of Excellence
2015
India — Inaugural Edition
The first MCADDI program, establishing the template for integrated medicinal chemistry education in India.
2019
Biocon Academy, Bangalore
100+ attendees from industry and academia. Landmark return with expanded curriculum and international faculty.
2020
Virtual Edition
Successfully adapted to virtual format, maintaining the global faculty and full curriculum through the pandemic.
Latest
2024
Biocon Academy, Bangalore
32 lectures · 17 speakers · BMS, Genentech, AbbVie, Schrodinger, Sun Pharma & more · Keynote by Kiran Mazumdar Shaw.
4Editions completed
100+Participants per edition
50+Speakers over the years
10+Years of MCADDI
Scientific program
Key Thematic Areas
30+ lectures spanning the complete drug discovery and development paradigm — from first principles to the clinic.
01 — Discovery & Design
Target identification & lead optimization
- Target identification & validation
- Principles of medicinal chemistry
- Hit identification, HTS & virtual screening
- Hit-to-lead & lead optimization
- Structure-based & AI-driven drug design
- Molecular modelling & in silico tools
- Drug-like & physicochemical properties
02 — Development & Translation
From bench to bedside
- Drug metabolism & pharmacokinetics
- Bioisosteres & prodrugs in drug design
- Designing around toxicophores
- Preclinical & translational ADME/PK
- Clinical development & regulatory pathways
- Biopharmaceutics & formulation
- Process chemistry & manufacturing
03 — Advanced Modalities
Next-generation therapeutics
- Biologics & monoclonal antibodies
- Antibody-drug conjugates (ADCs)
- Protein degraders & molecular glues
- G-protein coupled receptors
- AI in pharma & biotech
- Enzymes, receptors & ion channels
- Integrated drug discovery case histories
Why attend
Program Highlights
Global faculty from industry & academia
Leading scientists from top global pharma companies and research institutions across the US, Europe, and India.
Discovery-to-development approach
An integrated curriculum following a drug from initial target all the way to manufacturing — unmatched in breadth.
Case-based learning
Real-world drug discovery case histories presented by scientists who personally led the programs.
Networking & collaboration
Six days of structured and informal networking with peers, faculty, and industry leaders from across the globe.
CEO conclave & keynote
Exclusive fireside chat with pharma & biotech CEOs and a banquet keynote — a signature feature unique to MCADDI.
Integrated curriculum & booklet
A comprehensive printed program booklet — a lasting scientific reference for all participants to take home.
Schedule overview
6-Day Program Structure
Each day runs from 8:30 AM with lectures, case studies, and networking breaks. One evening features the CEO conclave and banquet.
Day 1 — Sunday, Oct 25
Arrival, Registration & Foundations
- Registration from 11:00 AM
- Welcome address
- Principles of medicinal chemistry (Parts 1 & 2)
- Target identification & validation
- Reception & dinner
Days 2–3 — Mon–Tue, Oct 26–27
Discovery & Design
- Hit identification, HTS & virtual screening
- Drug-like & physicochemical properties
- Enzymes, receptors & ion channels
- Molecular interactions & structure-based design
- Hit-to-lead & lead optimization
- In silico tools & AI in drug discovery
- G-protein coupled receptors
- Bioisosteres in drug design
Days 4–5 — Wed–Thu, Oct 28–29
Development, Translation & Advanced Modalities
- Drug metabolism, PK & disposition
- Preclinical to clinical translational ADME
- Prodrugs in drug discovery
- Introduction to biologics (Parts 1 & 2)
- Antibody-drug conjugates (ADCs)
- Protein degraders & molecular glues
- Biopharmaceutics & developability
- CEO conclave & fireside chat
- Evening reception & banquet
Day 6 — Fri, Oct 30
Process, Case Histories & AI
- Designing around toxicophores
- Process chemistry & manufacturing
- Integrated drug discovery case histories
- AI applications in pharma & biotech
- Applications of heterocycles in drug design
- First-in-class drug discovery case history
- Concluding remarks & certificate distribution
Throughout the week
Networking & Special Sessions
- Daily coffee & tea breaks
- Lunch & learn sessions (industry sponsors)
- Exhibition hall & sponsor booths
- CEO conclave & fireside chat
- Evening reception & banquet
Special focus
Dedicated AI Afternoon Session
- AI-driven drug design & discovery
- Machine learning in medicinal chemistry
- In silico screening & molecular modelling
- Real-world AI case studies from industry
- Panel discussion on AI in pharma & biotech
Benefits
What You Get
Certificate of completion
Issued to all participants who complete the full 6-day program.
Program booklet
Comprehensive printed compendium of all lectures and presentations to take home.
Global faculty access
Six days of direct interaction with 30+ leading scientists from global pharma and academia.
Networking opportunities
Connect with peers, industry leaders, and potential collaborators from 7+ countries.
FAQs
Frequently Asked Questions
Is accommodation included in the registration fee?
Accommodation is not included. However, the organizing team will share a list of recommended hotels near the University of Hyderabad, and transport between accommodation and the venue will be facilitated.
Will I receive a certificate of completion?
Yes. All participants who attend the full 6-day program will receive a certificate of completion from the organizing institutions.
Can students attend? What is the registration fee for students?
Yes, students are strongly encouraged to attend. The academic registration fee of ₹24,000 applies to Bachelors, Masters, PhD, postdoctoral researchers, and faculty — making this program accessible to learners at all career stages.
Will sessions be recorded or available online?
No. MCADDI is an in-person immersive program. Sessions will not be recorded. This is by design — the interactive, case-based format and networking opportunities are central to the experience.
Can my company sponsor the event or sponsor seats?
Yes. Sponsorship opportunities are available at Platinum (₹10 lakhs), Gold (₹5 lakhs), and Silver (₹2.5 lakhs) levels, including exhibition booth options. Companies can also use CSR funds. However, all participants — including those from sponsoring companies — must register individually. Write to info@biofaba.org.in for sponsorship details.
Are registrations still open?
Registrations for MCADDI 2026 are now closed. Registered participants will receive joining details by email. For any queries, write to info@biofaba.org.in or call +91 7989957263.
Who are the speakers for MCADDI 2026?
The 2026 speaker list is being finalized and will be announced shortly. MCADDI 2024 featured 17 speakers from institutions including Bristol-Myers Squibb, Genentech, AbbVie, Schrodinger, Sun Pharma, and Aurigene. A similarly distinguished lineup is expected for 2026.
Is there a refund policy?
Refund details will be communicated at the time of registration. Please write to info@biofaba.org.in for queries regarding cancellation or transfer of registration.
Faculty 2026
Speakers
Speakers will be announced soon
We are finalizing an outstanding faculty from global pharma, biotech, and academia. Check back soon for the confirmed speaker list.
MCADDI 2024 faculty
Past Edition Speakers
MCADDI 2024 featured 17 exceptional speakers from leading global institutions. Expect a similarly distinguished lineup for 2026.
KMS
Kiran Mazumdar Shaw
Biocon, India
Keynote Speaker — Banquet 2024
TP
Prof. Thomas Prisinzano
Univ. of Kentucky, USA
Medicinal Chemistry Principles · Drug-Like Properties
NM
Dr. Nick Meanwell
Baruch S. Blumberg Institute, USA
Bioisosteres · Toxicophores · Heterocycles · Fostemsavir
BE
Bruce Ellsworth
Bristol-Myers Squibb, USA
Hit-to-Lead · Protein Degraders · Integrated Drug Discovery
ME
Martin Eastgate
Bristol-Myers Squibb, USA
Process Chemistry · Integrated Process Development
SM
Dr. Sandhya Mandlekar
Genentech, USA
Drug Metabolism · PK/PD · Translational ADME
VS
Vincent S. Stoll
AbbVie, USA
Molecular Interactions · Structure-Based Drug Design
MR
Dr. Manjunath Ramarao
Atomic AI, USA
Target ID · GPCRs · Enzymes & Ion Channels
RL
Rachel Lagiakos
Schrodinger, USA
In-Silico Tools · AI Applications in Drug Discovery
SD
Sridhar Desikan
Nexus, USA
Biopharmaceutics & Developability Characteristics
RM
Rustom Mody
Sun Pharma, India
Introduction to Biologics (Parts 1 & 2)
ND
Nitin Damle
Sun Pharma, India
Antibody-Drug Conjugates Case History
MRC
Murali Ramachandra
Aurigene Oncology, India
Macrophage Checkpoint Inhibitor Case History
MJ
Dr. Mukul Jain
Zydus, India
Integrated Drug Discovery & Development
NG
Dr. Nagaraj Gowda
Glenmark Pharmaceuticals
HPK1 Clinical Candidate GRC 54276
CM
Dr. CSN Murthy
Satya Pharma Innovation, India
RAD51:BRCA2 Pan-Cancer Drug Discovery
AP
Ashok Purandare
Bristol-Myers Squibb, USA
Targeted Protein Degraders & Molecular Glues
* Speaker list above is from MCADDI 2024. MCADDI 2026 speakers will be announced shortly.
Audience
Who Should Attend
Biotech & pharma professionals
Scientists & researchers in pharma & life sciences
Bachelors, Masters, PhD students & postdoctoral researchers
Faculty & academic researchers in life sciences
Professionals from CRO, CDMO & allied healthcare sectors
Regulatory, clinical & drug development professionals
Partners
About the Organisers
Federation of Asian Biotech Associations (FABA)
A non-profit established in 2004 connecting academia, industry, and government. FABA Academy bridges the gap through professional development programs for science graduates across India and Asia.
Science Gurus
A US-based non-profit providing science education, training, and mentorship for the next generation of STEM professionals, supporting students in the South Asian community in the US and India.
University of Hyderabad
One of India's Institutions of Eminence, a nationally-ranked public university founded in 1974. The School of Life Sciences at UoH is the host venue for MCADDI 2026.
Biocon Academy
Center of Excellence for Advanced Learning in Applied Biosciences. Host of MCADDI 2019 & 2024 in Bangalore. Continues to support website management, registrations, and scientific coordination.
Strategic Pharma Innovation-Sourcing Center LLC
US-based organization led by Dr. Balu Balasubramanian, founding architect of MCADDI. Coordinates global faculty engagement and scientific program design across all editions.
MedChem Discovery Consulting LLC
Led by Dr. William Greenlee, Co-Chair of the MCADDI Advisory Board. Provides scientific direction and oversight of the program curriculum across all editions.
Supported by
ACS American Chemical Society · Medicinal Chemistry Division
IUPAC Human Health Division
Registration
Registrations Closed
Registrations Closed
MCADDI 2026 registrations are now closed
We thank everyone for the tremendous response to MCADDI 2026, October 25–30, 2026, at the University of Hyderabad.
Registered participants will receive joining details and program information by email.
For any queries, write to info@biofaba.org.in or call +91 7989957263
Get in touch
Contact Us
OrganisationFederation of Asian Biotech Associations (FABA)
AddressVindhya C4, II Floor, IIIT Hyderabad
Gachibowli, Hyderabad – 500032
Gachibowli, Hyderabad – 500032
Phone+91 7989957263
Emailinfo@biofaba.org.in
Websitewww.biofaba.org.in
Program websitemcaddi-course.com
University of Hyderabad
Gachibowli, Hyderabad – 500046
Gachibowli, Hyderabad – 500046